Health
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
Key Points
Daraxonrasib, a newly approved treatment for pancreatic cancer made by Revolution Medicines.
Daraxonrasib, a newly approved treatment for pancreatic cancer made by Revolution Medicines.